Evidence map›Paper›PMID 36975440›Full record

ArticleCurrent oncology (Toronto, Ont.)2023

Association of DNA Promoter Methylation and

Farzana Jasmine, Briseis Aschebrook-Kilfoy, Mohammad M Rahman, Garrett Zaagman, Raymon H Grogan, Mohammed Kamal, Habibul Ahsan, Muhammad G Kibriya

Open access · goldFull text read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. The role of epigenetic methylations in thyroid Cancer.World journal of surgical oncology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Farzana JasmineInstitute for Population and Precision Health, Biological Sciences, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0002-5980-1174
Briseis Aschebrook-KilfoyInstitute for Population and Precision Health, Biological Sciences, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0003-1918-7816
Mohammad M RahmanDepartment of Pathology, Bangabandhu Sheikh Mujib Medical University, Dhaka 1000, Bangladesh.
Garrett ZaagmanInstitute for Population and Precision Health, Biological Sciences, University of Chicago, Chicago, IL 60637, USA.
Raymon H GroganDepartment of Surgery, Baylor St. Luke's Medical Center, Houston, TX 77030, USA.
Mohammed KamalDepartment of Pathology, The Laboratory, Dhaka 1205, Bangladesh.
Habibul AhsanInstitute for Population and Precision Health, Biological Sciences, University of Chicago, Chicago, IL 60637, USA.
Muhammad G KibriyaInstitute for Population and Precision Health, Biological Sciences, University of Chicago, Chicago, IL 60637, USA.ORCID 0000-0001-9784-6958
Chicago Department of Public Health · USUniversity of Chicago · USBangladesh Medical University · BDSt. Luke's Hospital · US

Funding

Bangladesh Center of Research Excellence in Non-communicable Disease- Planning UnitP20CA210305 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL, ISLAM, SYED SHARIFUL · 2016 to 2017
$524k
NCI NIH HHS P20 CA210305
6 · The paper itself

Abstract

The

Indexed as

Carcinoma, PapillaryThyroid NeoplasmsDNADNA MethylationFemaleHumansMaleMutationProto-Oncogene Proteins B-rafBRAF protein, humanDNAProto-Oncogene Proteins B-rafBRAF mutationmethylationRAS signalingthyroid carcinomaTNFR2

Identifiers

PMID36975440
PMCPMC10047424
OpenAlexW4322760633

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read35
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.